Delphia (Usa) Inc. Vir Biotechnology, Inc. Transaction History

Delphia (Usa) Inc.

  • $0
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$19.08 - $26.7 $253,306 - $354,469
-13,276 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$21.19 - $40.01 $155,365 - $293,353
7,332 Added 123.35%
13,276 $341,000
Q4 2021

Feb 14, 2022
BUY
$30.97 - $54.03 $184,085 - $321,154
5,944 New
5,944 $249,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $982M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Delphia (Usa) Inc. Portfolio

Follow Delphia (Usa) Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

News

Stay updated on Delphia (Usa) Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email